No Detail Found!

Awareness Regarding Parkinson's Disease: a Survey Report.

Author(s)
Sana Sarfaraz Department of Pharmacology, Faculty of Pharmacy, Jinnah University for Women Karachi, 74600, Pakistan
Abeer Sarfaraz Jinnah Postgraduate and Medical center Karachi 74600, Pakistan
Abstract
Parkinson disease also known as paralysis agitans is a neurodegenerative disorder. It is thought to occur as a result of decline of dopamine secreting cells in substantia nigra. The common symptoms related to Parkinson are tremors, rigidity, slowness of movement and dementia. The purpose of this study was to evaluate awareness regarding Parkinson disease, its cause, symptoms, diagnosis and treatment. The survey is conducted based on questionnaire, in which general population belonging to different public universities and government hospitals were questioned regarding Parkinson disease. The ratio found was not upto our expectations as less than 55 people( out of 210) knew the name of the disease but only 18 of them were aware about the causes and symptoms associated with it and even lower awareness was observed regarding diagnosis and treatment of disease. From this survey we found that awareness regarding parkinsons disease is negligible in general population.
Publication Details
Page(s) 23-27
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 2, Issue: 1, Year: 2014

Request the full text from PASTIC

Keywords
Dopamine, Alpha Synuclein Protein, Deep Wave Stimulation, Monoamino Oxidase B Inhibitors and Parkinson
References
De LauLM,BretelerMM, 2006."Epidemiology of Parkinson's disease",Lancet Neurol 5 525 -35
SamiiA,NuttJG,RansomBR, 2004."Parkinson's disease",Lancet 363 1783 -93
JankovicJ, 2008."Parkinson's disease: clinical features and diagnosis",J. Neurol. Neurosurg. Psychiatr 79 368 -76
Barnett-CowanM,DydeRT,FoxeSH,MoroE,HutchisonWD,HarrisLR, 2010."Multisensory determinants of orientation perception in Parkinson's disease",Neuroscience 167 1138 -50
LesageS,BriceA, ."Parkinson's disease: from monogenic forms to genetic susceptibility factors", -
ObesoJA,Rodriguez-OrozMC,GoetzCG, 2010."Missing pieces in the Parkinson's disease puzzle",Nat. Med 16 653 -61
ObesoJA,Rodríguez-OrozMC,BenitezTeminoB, 2008."Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease",Mov. Disord 23 S548 -59
VanMaele-Fabry,G , Hoet,P , Vilain,F , Lison,D., 2012."Occupational exposure to pesticides and Parkinson's disease: a systematic review and meta-analysis of cohort studies",Environ Int 46 30 -43
Brooks DJ, 2010."Imaging approaches to Parkinson disease",J. Nucl. Med 51 596 -609
CostaJ,LunetN,SantosC,SantosJ,VazCarneiroA, 2010."Caffeine exposure and the risk of Parkinson's disease: a systematic review and metaanalysis of observational studies",J. Alzheimers Dis 20 S221 -
QuikM,HuangLZ,ParameswaranN,BordiaT,CamposC,Perez XA, 2009."Multiple roles for nicotine in Parkinson's disease",Biochem Pharmacol 78 677 -85
SuchowerskyO,GronsethG,PerlmutterJ,ReichS,ZesiewiczT,WeinerWJ, 2006."Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology",Neurology 66 976 -82
FahnS,OakesD,ShoulsonI, 2004.Levodopa and the progression of Parkinson's disease,New England Journal of Medicine 351 2498 -2508
BaroneP,BraviD,Bermejo-ParejaF, 1999.Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide M o n o t h e r a p y S t u d y G r o u p . N e u r o l o g y ; 53(3, 573 -579
BirkmayerW,KnollJ,RiedererP, 1985.Increased life expectancy resulting from addition of L-deprenyl to madopar treatment in Parkinson's disease: a longterm study,Journal of Neural Transmission; 64 113 -127
LenzFA,TaskerRR,KwanHC, 1987.Selection of the optimal lesion site for the relief of parkinsonian tremor on the basis of spectral analysis of neuronal firing patterns, 50 338 -43
LimousinP,PollakP,BenazzouzA, 1995.Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation, 345 91 -95
0

Citations

0

Downloads

126

Views